HK1002019A1 - Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-YN-3-one - Google Patents
Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-YN-3-oneInfo
- Publication number
- HK1002019A1 HK1002019A1 HK98101031A HK98101031A HK1002019A1 HK 1002019 A1 HK1002019 A1 HK 1002019A1 HK 98101031 A HK98101031 A HK 98101031A HK 98101031 A HK98101031 A HK 98101031A HK 1002019 A1 HK1002019 A1 HK 1002019A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- compound
- pregn
- hydroxy
- methyl
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL8900673 | 1989-03-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1002019A1 true HK1002019A1 (en) | 1998-07-24 |
Family
ID=19854317
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK98101031A HK1002019A1 (en) | 1989-03-18 | 1998-02-11 | Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-YN-3-one |
Country Status (17)
Country | Link |
---|---|
US (1) | US5037817A (ja) |
EP (1) | EP0389035B1 (ja) |
JP (2) | JP3139709B2 (ja) |
KR (1) | KR0183401B1 (ja) |
AT (1) | ATE98490T1 (ja) |
AU (1) | AU625083B2 (ja) |
CA (1) | CA2011452C (ja) |
DE (1) | DE69005165T2 (ja) |
DK (1) | DK0389035T3 (ja) |
ES (1) | ES2062292T3 (ja) |
FI (1) | FI94865C (ja) |
HK (1) | HK1002019A1 (ja) |
IE (1) | IE63051B1 (ja) |
MX (1) | MX9203787A (ja) |
NZ (1) | NZ232946A (ja) |
PT (1) | PT93488B (ja) |
ZA (1) | ZA901674B (ja) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0613687T3 (da) * | 1993-03-05 | 1999-12-06 | Akzo Nobel Nv | Anvendelse af pregnanderivat til behandling af tumorer |
US6242434B1 (en) * | 1997-08-08 | 2001-06-05 | Bone Care International, Inc. | 24-hydroxyvitamin D, analogs and uses thereof |
IL123984A (en) * | 1997-04-22 | 2004-09-27 | Akzo Nobel Nv | Pharmacological dosage units containing tibolone and carrier pharmacy are acceptable |
TR200101083T2 (tr) * | 1998-10-16 | 2001-08-21 | Akzo Nobel N.V. | (7alfa,17alfa)-17-hidroksi- 7-metil-19-nor-17-pregn-5 (10)-en-20-in-3-on içeren yüksek saflıkta bileşim. |
US7045513B1 (en) | 1999-03-18 | 2006-05-16 | Genelabs Technologies, Inc. | DHEA composition and method |
RU2220727C2 (ru) * | 1999-03-18 | 2004-01-10 | Дженелабс Текнолоджис, Инк. | Композиция, содержащая дегидроэпиандростерон, и способы ее изготовления и применения |
TWI265167B (en) * | 1999-11-29 | 2006-11-01 | Akzo Nobel Nv | 3-methylene steroid derivatives |
US20040229854A1 (en) * | 2000-11-28 | 2004-11-18 | Pieter Haan De | Immediate release dosage form for HRT |
AU2002347973A1 (en) * | 2001-10-18 | 2003-04-28 | Ivax Corporation | Novel tibolone formulations |
GB0125061D0 (en) * | 2001-10-18 | 2001-12-12 | Norton Healthcare Ltd | Pharmaceutical composition |
RU2004125594A (ru) * | 2002-01-22 | 2005-03-10 | Акцо Нобель Н.В. (NL) | Применение тиболона при лечение симптомов, связанных с введением лекарств, препятствующих синтезу эндогенного эстрогена |
GB0304927D0 (en) | 2003-03-04 | 2003-04-09 | Resolution Chemicals Ltd | Process for the production of tibolone |
CN1324041C (zh) * | 2003-04-01 | 2007-07-04 | 上海迪赛诺医药科技开发有限公司 | 替勃龙晶型i的制备方法 |
PL1499278T3 (pl) * | 2003-05-23 | 2005-09-30 | Msd Oss Bv | Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon |
WO2006125453A1 (en) * | 2005-05-23 | 2006-11-30 | Newchem S.P.A. | Process for the preparation of pure crystalline tibolone |
EP1821571A1 (en) * | 2006-02-15 | 2007-08-22 | Oticon A/S | Loop antenna for in the ear audio device |
ITMI20130120A1 (it) * | 2013-01-25 | 2014-07-26 | Ind Chimica Srl | Processo per la preparazione in forma cristallina di tibolone, (7alfa,17alfa)-17-idrossi-7-metil-19-norpregn-5(10)-en-20-in-3-one |
HUE055164T2 (hu) | 2016-05-04 | 2021-11-29 | Novalon S A | Cukoralkoholok alkalmazása Tobolon tartalmú készítményekben |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE665514A (ja) * | 1964-06-16 | |||
US4933168A (en) * | 1975-05-27 | 1990-06-12 | Syntex Pharmaceuticals International Limited | Stable, crystalline flunisolide |
US4273710A (en) * | 1979-05-21 | 1981-06-16 | Syntex Corporation | Process for preparing flunisolide |
US4447426A (en) * | 1982-01-18 | 1984-05-08 | E. R. Squibb & Sons, Inc. | Steroid monohydrates, formulations containing same and method |
US4391755A (en) * | 1982-01-18 | 1983-07-05 | E. R. Squibb & Sons, Inc. | Steroid monohydrates, formulations containing same and method |
US4701450A (en) * | 1984-03-21 | 1987-10-20 | Akzo N.V. | Steroids for use as immunomodulators |
-
1990
- 1990-02-27 IE IE70990A patent/IE63051B1/en not_active IP Right Cessation
- 1990-03-05 CA CA002011452A patent/CA2011452C/en not_active Expired - Lifetime
- 1990-03-05 ZA ZA901674A patent/ZA901674B/xx unknown
- 1990-03-12 EP EP90200574A patent/EP0389035B1/en not_active Expired - Lifetime
- 1990-03-12 DE DE90200574T patent/DE69005165T2/de not_active Expired - Lifetime
- 1990-03-12 ES ES90200574T patent/ES2062292T3/es not_active Expired - Lifetime
- 1990-03-12 DK DK90200574.3T patent/DK0389035T3/da active
- 1990-03-12 AT AT90200574T patent/ATE98490T1/de not_active IP Right Cessation
- 1990-03-14 JP JP02063921A patent/JP3139709B2/ja not_active Expired - Lifetime
- 1990-03-15 US US07/494,089 patent/US5037817A/en not_active Expired - Lifetime
- 1990-03-16 FI FI901328A patent/FI94865C/fi active IP Right Grant
- 1990-03-16 NZ NZ232946A patent/NZ232946A/xx unknown
- 1990-03-16 AU AU51394/90A patent/AU625083B2/en not_active Expired
- 1990-03-16 PT PT93488A patent/PT93488B/pt not_active IP Right Cessation
- 1990-03-17 KR KR1019900003574A patent/KR0183401B1/ko not_active IP Right Cessation
-
1992
- 1992-06-29 MX MX9203787A patent/MX9203787A/es unknown
-
1998
- 1998-02-11 HK HK98101031A patent/HK1002019A1/xx not_active IP Right Cessation
-
2000
- 2000-10-17 JP JP2000316716A patent/JP2001139473A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US5037817A (en) | 1991-08-06 |
ES2062292T3 (es) | 1994-12-16 |
KR0183401B1 (ko) | 1999-05-01 |
DE69005165D1 (de) | 1994-01-27 |
KR900013950A (ko) | 1990-10-22 |
IE63051B1 (en) | 1995-03-22 |
PT93488B (pt) | 1996-02-29 |
IE900709L (en) | 1990-09-18 |
ZA901674B (en) | 1990-12-28 |
DK0389035T3 (da) | 1994-02-14 |
CA2011452A1 (en) | 1990-09-18 |
AU5139490A (en) | 1990-09-20 |
FI901328A0 (fi) | 1990-03-16 |
MX9203787A (es) | 1992-07-01 |
AU625083B2 (en) | 1992-07-02 |
EP0389035A1 (en) | 1990-09-26 |
NZ232946A (en) | 1991-08-27 |
JP2001139473A (ja) | 2001-05-22 |
JPH0347195A (ja) | 1991-02-28 |
ATE98490T1 (de) | 1994-01-15 |
EP0389035B1 (en) | 1993-12-15 |
CA2011452C (en) | 1999-05-25 |
FI94865C (fi) | 1995-11-10 |
FI94865B (fi) | 1995-07-31 |
JP3139709B2 (ja) | 2001-03-05 |
PT93488A (pt) | 1990-11-07 |
DE69005165T2 (de) | 1994-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1002019A1 (en) | Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-YN-3-one | |
IL102616A0 (en) | 1,3-oxathiolane nucleoside analogues,methods for the preparation thereof and pharmaceutical compositions containing the same | |
HU9200302D0 (en) | 1,3-oxatiolane-nucleotide analogues | |
AU6290090A (en) | Bi-or trispecific (fab)3 or (fab)4 conjugates | |
AR244666A1 (es) | Procedimiento para preparar compuestos piperidinilicos 1,4-disustituidos, utiles como analgesicos y relajantes musculares. | |
EP0221728A3 (en) | Monosaccharide containing wound healing preparation | |
AU4717089A (en) | N-(3,4-Dioxy-and N-(4-oxy-3-thio-benzyl)-thioureas | |
NZ226516A (en) | 2,2 dimethylchromene derivatives and pharmaceutical compositions | |
HUT65702A (en) | 1,2-dithiole-3-thione-derivative-based therapeutical compositions | |
OA09192A (en) | "Stabilized sulfur dissolving compositions". | |
EP0352085A3 (en) | Electron microscope | |
NZ234369A (en) | 6-(naphthalenylethyl)-4-hydroxy-pyran-2-one derivatives and the 3,5-dihydroxyheptanoates; pharmaceutical compositions | |
IL95210A0 (en) | 14,17alpha-etheno-and-ethanoestratrienes,process for the preparation thereof and pharmaceutical compositions containing the same | |
AU5388090A (en) | N-sulfenyl- and n-sulfinyl-n,n'-diacylhydrazides | |
NZ227235A (en) | Substituted 1,5-benzothiazepin-4-one derivatives and pharmaceutical compositions | |
NZ228023A (en) | 24(r)-scymnol; preparatory processes and pharmaceutical compositions | |
IL101482A0 (en) | Substituted 2',3'-dideoxy-5-trifluoromethyluridines,and pharmaceutical compositions containing them | |
OA09440A (en) | "Transformed shigella". | |
NZ224313A (en) | Hetero-ring condensed quinolineamines and pharmaceutical compositions | |
AU4718989A (en) | 4-amino-5-nitro-1,2,3,6-tetrahydropyrimidines | |
AU1117188A (en) | 14,15-substituted lanosterols and their use as hypocholesterolemic agents | |
AU2403592A (en) | 2-aza-2-desamino analogues of 5,8-dideazafolic acid | |
EP0293633A3 (en) | 1,2-di(4-isobutylphenyl)hydrocarbon and its preparation and use as intermediate | |
NZ224728A (en) | 3-acylaminomethyl-5,6,7,8-tetrahyd-pyridine derivatives and pharmaceutical compositions | |
IL91315A0 (en) | 2,3,4,5-tetrahydro-1-benzoxepins,a process for the preparation thereof and pharmaceutical compositions based on these compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PE | Patent expired |
Effective date: 20100311 |